U.S. FDA cleared the new iCare MAIA microperimeter
Revenio Group Corporation | Press Release | March 28, 2025 at 09:00:00 EET Icare, a subsidiary of Revenio Group, has today announced that the U.S. Food and Drug Administration (FDA) has cleared the new iCare MAIA microperimeter. This clearance marks a significant milestone in our growth and innovation strategy, aimed at better meeting market diagnostic […]
Read more ›